Furthermore, a recent study using genome-wide small interfering RNA (siRNA) screening identified RBBP9 as a synthetic lethal gene essential for tumor cells deficient in Fanconi anemia (FA) proteins in a head-and-neck squamous cell carcinoma (HNSCC) model.14 The gene discussed is RBBP9; the disease is Friedreich ataxia.